Medlab Clinical Limited

    Medlab Clinical Limited

    AASX:MDC
    - -
    AUD
    - -
    - -
    Medlab Clinical Limited
    ASX:MDC
    (Australian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2014
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    AUD
    - -
    1.57
    2.8
    3.25
    3.9
    1.89
    2.24
    84.33
    0.39
    0.01
    Revenue per Share
    - -
    -3.19
    -3.11
    -3.58
    -5.81
    -8.9
    -6.27
    -471
    -2.97
    -0.93
    Basic EPS, GAAP
    - -
    -0.07
    -0.06
    -0.08
    -0.24
    -0.16
    -0.04
    -1.88
    -0.01
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.14
    2.27
    3.25
    17.89
    10.75
    7.52
    7.35
    478.86
    0.51
    -0.37
    Book Value per Share
    0.14
    1.73
    2.6
    17.14
    10.76
    7.48
    7.58
    509.58
    0.56
    -0.37
    Tangible Book Value per Share
    74
    1
    1
    1
    1
    2
    2
    - -
    2
    2
    Basic Weighted Avg Shares
    - -
    2
    3
    4
    5
    3
    4
    1
    1
    - -
    Sales/Revenue/Turnover
    - -
    -267.48
    -151.25
    -147.61
    -197.89
    -570.72
    -363.43
    -1,016.46
    -1,107.84
    -18,990.81
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    - -
    Depreciation Expense
    - -
    -3
    -4
    -5
    -8
    -13
    -12
    -7
    -7
    -2
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    -202.95
    -111.14
    -110.41
    -148.95
    -470.42
    -280.12
    -558.5
    -759.84
    -17,913.57
    Profit Margin (%)
    10
    2
    3
    21
    14
    10
    14
    6
    1
    -1
    Working Capital
    - -
    - -
    - -
    - -
    - -
    2
    1
    1
    - -
    - -
    LT Debt
    10
    2
    3
    22
    15
    11
    15
    8
    1
    -1
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    -53.15
    -116.09
    -34.33
    -42.82
    -101.91
    -95.67
    -65.93
    -160.52
    - -
    Return on Common Equity (%)

    Capital Structure

    AUD

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    AUD

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    AUD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -58.09%
    -166.47%
    Free Cash Flow
    - -
    - -
    - -
    Net Income, GAAP
    - -
    -11.65%
    -68.57%
    Sales/Revenue/Turnover
    - -
    -38.61%
    -98.67%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    AUD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    1
    2023
    - -
    - -
    - -
    - -
    1
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    AUD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    -471
    2023
    - -
    - -
    - -
    - -
    -2.97
    2024
    - -
    - -
    - -
    - -
    -0.93

    Quarterly Dividends Per Share

    AUD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business